Annals of Allergy Asthma & Immunology

Article	Citations
Atopic dermatitis in the pediatric population	162
New treatments in atopic dermatitis	112
Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis	76
The infectious complications of atopic dermatitis	72
The journey to a respiratory syncytial virus vaccine	69
Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States	61
Asthma and the social determinants of health	60
Potential association of mast cells with coronavirus disease 2019	59
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma	58
Smell loss is a prognostic factor for lower severity of coronavirus disease 2019	53
Biologics in chronic rhinosinusitis with nasal polyposis	52
Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis	49
New and emerging treatments for inflammatory itch	47
The COVID-19 pandemic	47
Prevalence and natural history of tree nut allergy	46
Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019	45
Hereditary alpha-tryptasemia in 101 patients with mast cell activation–related symptomatology including anaphylaxis	42
Key steps in vaccine development	42
Children with reported penicillin allergy	42
Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters	40
The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection	40
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis	40
The impact of psychological stress on mast cells	39
Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions	38
Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic	38

Secondary immunodeficiencies	37
Phenotypes and endotypes in eosinophilic esophagitis	37
The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019	36
AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis	36
Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines	33
Chronic stress and asthma in adolescents	32
Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies	32
Making the GRADE in anaphylaxis management	31
Quality of life in food allergic children	30
Tezepelumab improves patient-reported outcomes in patients with severe, uncontrolled asthma in PATHWAY	30
Real-world persistence with dupilumab among adults with atopic dermatitis	30
Diagnostic testing for galactose-alpha-1,3-galactose, United States, 2010 to 2018	30
COVID-19, severe asthma, and biologics	30
Social media and its impact on health care	29
High anxiety and health-related quality of life in families with children with food allergy during coronavirus disease 2019	29
Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019	29
Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma	28
Clinical relevance of inherited genetic differences in human tryptases	28
Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency	28
A review of contact dermatitis	28
A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency	27
Engaging patient partners in state-of-the-art allergy care	27
Reaction phenotypes in IgE-mediated food allergy and anaphylaxis	27
Current medical management of hereditary angioedema	26
Biologics in eosinophilic gastrointestinal diseases	26
Prenatal PM2.5 exposure and vitamin D–associated early persistent atopic dermatitis via placental methylation	25
Asthma in patients with coronavirus disease 2019	25
Evaluating the impact of coronavirus disease 2019 on asthma morbidity	25
Intralymphatic immunotherapy for mountain cedar pollinosis	25
Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic	25
One march, many paths: Insights into allergic march trajectories	24
Preoperative penicillin allergy testing in patients undergoing cardiac surgery	24
GINA updated 2019	24
Inherited and acquired determinants of serum tryptase levels in humans	24
Food protein-induced enterocolitis syndrome epidemiology	24
Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions	24
Shared decision-making in the care of a patient with food allergy	24
Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use	23
A scoping review of the caregiver burden of pediatric food allergy	23
Clinical and economic burden of severe asthma among US patients treated with biologic therapies	23
Bleach baths for atopic dermatitis	23
The origins of allergy from a systems approach	22
Epithelial cell function and remodeling in nasal polyposis	22
Association of itch triggers with atopic dermatitis severity and course in adults	22
Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy	22
Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin	22
Qualitative analysis of perceived impacts on childhood food allergy on caregiver mental health and lifestyle	22
Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic	22
Asthma, biologics, corticosteroids, and coronavirus disease 2019	22
Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin	22

Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients	21
Advances in understanding immune mechanisms of food protein–induced enterocolitis syndrome	21
Skin testing and oral amoxicillin challenge in the outpatient allergy and clinical immunology clinic in pregnant women with penicillin allergy	21
Unmet needs of children with peanut allergy	21
Food allergy-related bullying and associated peer dynamics among Black and White children in the FORWARD study	21
Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma	21
Fatal food anaphylaxis	20
Food insecurity in children and adults with food allergies	20
Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race	20
A review of shared decision-making	20
Factors contributing to underuse of epinephrine autoinjectors in pediatric patients with food allergy	20
Clinical guidance for the use of dupilumab in eosinophilic esophagitis	19
Incidence of and risk factors for perioperative or periprocedural anaphylaxis in the United States from 2005 to 2014	19
Outside-in hypothesis revisited	19
Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination	19
Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy	19
Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study	19
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines	19
Childhood atopic dermatitis is associated with cognitive dysfunction	19
Future of allergic rhinitis management	19
Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019	18
Drug hypersensitivity in the fast lane	18
Traditional Chinese medicine for food allergy and eczema	18
Group 2 innate lymphoid cells in nasal polyposis	18
Prevention and treatment of recurrent viral-induced wheezing in the preschool child	18
Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy	18
Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy	18
Strategies for choosing a biologic for your patient with allergy or asthma	18
Health disparities in pediatric food allergy	18
Exercise-induced bronchoconstriction in elite or endurance athletes:	18
Future therapies for eosinophilic gastrointestinal disorders	17
Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia	17
Severe asthma exacerbations in the United States:	17
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019	17
Food protein-induced enterocolitis syndrome oral food challenge	17
Longitudinal effect of phthalates exposure on allergic diseases in children	17
Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis	17
Food reactions during avoidance	17
Assessment and feedback methods in competency-based medical education	17
Current and emerging treatments for chronic spontaneous urticaria	17
Impact of nasal polyps on endotype and phenotype in patients with moderate to severe asthma	17
Addressing the epidemic of antibiotic “allergy” over-diagnosis	17
Oral food challenges	16
The negative predictive value of 5-day drug provocation test in nonimmediate beta-lactam allergy in children	16
Impact of atopic dermatitis treatment on child and parent sleep, daytime functioning, and quality of life	16
Asthma in patients with suspected and diagnosed coronavirus disease 2019	16
Local immunoglobulin production in nasal tissues	16
Superior turbinate eosinophilia predicts olfactory decline in patients with chronic rhinosinusitis	16
Clinical aspects of sublingual immunotherapy tablets and drops	16
Racial disparities in allergic outcomes persist to age 10 years in black and white children	16
Clinical phenotyping of atopic dermatitis using combined itch and lesional severity	16
Immunizing the imperfect immune system	16
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis	16
Association between cognitive function and asthma in adults	16
Developing and evaluating ASTHMAXcel adventures	16
Tiotropium in children and adolescents with asthma	15
Predictors of severe anaphylaxis in Hymenoptera venom allergy	15
Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy	15
Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease	15
Atopic dermatitis and dementia risk	15
A butterfly flaps its wings	15
Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly	15
Detection of neutralizing anti–severe acute respiratory syndrome coronavirus 2 antibodies in patients with common variable immunodeficiency after immunization with messenger RNA vaccines	15
Associations of sleep duration with patient-reported outcomes and health care use in US adults with asthma	15
A real-world assessment of asthma with chronic rhinosinusitis	15
Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule	15
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps	15
Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities	15
Rhinitis prevalence and association with atopic dermatitis	14
Cow’s milk allergy prevention	14
Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease	14
State-of-the-art diagnostic evaluation of common variable immunodeficiency	14
Long-term pollen trends and associations between pollen phenology and seasonal climate in Atlanta, Georgia (1992-2018)	14
Parents of children with food allergy	14
Thymic stromal lymphopoietin, skin barrier dysfunction, and the atopic march	14
Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis	14
Early, continuing exposure to cow's milk formula and cow's milk allergy	14
Chronic adult food protein–induced enterocolitis syndrome	14
Food allergy, breastfeeding, and introduction of complementary foods in the New York Old Order Mennonite Community	14
Vitamin D and iron status in children with food allergy	14

The evolution of food protein–induced enterocolitis syndrome	13
Update on indoor allergens and their impact on pediatric asthma	13
Obesity-related asthma in children is characterized by T-helper 1 rather than T-helper 2 immune response: A meta-analysis	13
Real-world efficacy and safety of dupilumab use in the treatment of asthma	13
Psychological functioning and quality of life in patients with mastocytosis	13
The impact of levels of particulate matter with an aerodynamic diameter smaller than 2.5 μm on the nasal microbiota in chronic rhinosinusitis and healthy individuals	13
Relative efficacy and safety of inhaled corticosteroids in patients with asthma	13
Tuft cells in the pathogenesis of chronic rhinosinusitis with nasal polyps and asthma	13
Achieving the Quadruple Aim to deliver value-based allergy care in an ever-evolving health care system	13
Clinical application of nasal nitric oxide measurement in allergic rhinitis	13
Atopic Dermatitis Yardstick update	13
Differences in oral food challenge reaction severity based on increasing age in a pediatric population	13
Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics	13
Medication adherence in Medicare-enrolled older adults with asthma before and during the coronavirus disease 2019 pandemic	13
What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later	13
Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions	13
The association between duration of breastfeeding and childhood asthma outcomes	13
Optimizing emollient therapy for skin barrier repair in atopic dermatitis	13
Breaking down the complex pathophysiology of eosinophilic esophagitis	12
EoE disease monitoring	12
A counseling video with pre- and posttesting and checklist for oral immunotherapy consent improves participant knowledge	12
Omalizumab response in patients with asthma by number and type of allergen	12
Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity	12
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough	12
Socioeconomic determinants of food allergy burden	12
A real-world study of the longitudinal course of adult atopic dermatitis severity in clinical practice	12
Food protein–induced enterocolitis syndrome	12
The effect of tezepelumab on hospitalizations and emergency department visits in patients with severe asthma	12
On the surface	12
Inverse associations between food diversity in the second year of life and allergic diseases	12
How to compare the efficacy of biologic agents in asthma	12
Better maternal quality of life in pregnancy yields better offspring respiratory outcomes	12
Tick bite as a risk factor for alpha-gal–specific immunoglobulin E antibodies and development of alpha-gal syndrome	12
Insights into allergic risk factors from birth cohort studies	11
T2-low: what do we know?	11
Does allergen immunotherapy for allergic rhinitis prevent asthma?	11
Single-step direct drug provocation testing is safe for delabelling selected non–low-risk penicillin allergy labels	11
Serum-free immunoglobulin E	11
Yardstick for the medical management of chronic rhinosinusitis	11
Immune-related cutaneous adverse events due to checkpoint inhibitors	11
The use of microarray and other multiplex technologies in the diagnosis of allergy	11
Outcomes for clinical trials of food allergy treatments	11
Testosterone-to-estradiol ratio and lung function in a prospective study of Puerto Rican youth	11
Oral Janus kinase inhibitors for atopic dermatitis	11
Real-world patterns and implications of short-acting β2-agonist use in patients with asthma in the United States	11
Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy	11
Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine	11
The practical dietary management of food protein-induced enterocolitis syndrome	11
The spectrum of allergic ocular diseases	11
The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety	11
Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma	11
Safety and outcomes of penicillin allergy evaluation in pregnant women	11
Evaluation of hypersensitivity reactions to cancer chemotherapeutic agents in pediatric patients	11
Intrabreath oscillometry is a sensitive test for assessing disease control in adults with severe asthma	11
Physician well-being in allergy and immunology	11
Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens	11
Characteristics of patients with spontaneous resolution of sesame allergy	11
Shared decision making in allergic rhinitis	11
Effects of short- and long-acting beta-agonists on asthma exacerbations: a prospective cohort	11
Eosinophilic gastrointestinal disorders	11
Social determinants of health and primary immunodeficiency	10
Clinical course of asthma in 4 cases of coronavirus disease 2019 infection	10
Allergy and Immunology Physician Workforce	10
Asthma maintenance and reliever therapy	10
Predictors of nonresponse to dupilumab in patients with atopic dermatitis	10
Further evidence for association of YKL-40 with severe asthma airway remodeling	10
Association of IL13 genetic polymorphisms with atopic dermatitis	10
Should we apply a treatable traits approach to asthma care?	10
Trends in US hospitalizations for anaphylaxis among infants and toddlers	10
Sex effects in the association between airway microbiome and asthma	10
Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor–monoclonal antibodies and desensitization	10
The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis	10
Asthma interactions between obesity and other risk factors	10
Polyethylene glycol and polysorbate testing in 12 patients before or after coronavirus disease 2019 vaccine administration	10
Mechanisms and treatment of olfactory dysfunction in chronic rhinosinusitis	10
The epidemiology of food allergy in adults	10
Quality of life in patients with hereditary angioedema in Canada	10
Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada	10
Real-world evidence	10
Non–immunoglobulin E-mediated allergy associated with Pfizer-BioNTech coronavirus disease 2019 vaccine excipient polyethylene glycol	10
Prenatal and early-life exposure to indoor air-polluting factors and allergic sensitization at 2 years of age	10
Efficacy of type 2-targeted biologics in patients with asthma and bronchiectasis	10
Tezepelumab normalizes serum interleukin-5 and -13 levels in patients with severe, uncontrolled asthma	10
Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients	10
Optimizing topical management of atopic dermatitis	10
Relapsing chronic eosinophilic pneumonia treated successfully with benralizumab	10
Serum insulin-like growth factor-1, asthma, and lung function among British adults	10
Comorbid posttraumatic stress disorder and major depressive disorder are associated with asthma morbidity among World Trade Center workers	10
Hypersensitivity to tetracyclines	9
Eosinophilic esophagitis may persist after discontinuation of oral immunotherapy	9
Skin testing as a biomarker in drug allergy	9
Penicillin allergy delabeling	9
Asthma biologics	9
Use of omalizumab for management of idiopathic anaphylaxis	9
Gastrointestinal immunopathology of food protein–induced enterocolitis syndrome and other non-immunoglobulin E–mediated food allergic diseases	9